期刊文献+

血管紧张素Ⅱ对乳腺癌细胞迁移的影响 被引量:1

Angiotensin Ⅱ Promotes the Migration of Breast Cancer Cells
下载PDF
导出
摘要 乳腺癌是女性发病率高且恶性程度高的肿瘤,肿瘤侵袭转移是导致患者死亡的重要原因,研究与癌细胞转移相关的因子或指标具有重要意义.本实验采用血管紧张素Ⅱ(AngⅡ)处理乳腺癌细胞MDA-MB-231,可促进肿瘤细胞迁移,增强到1.51倍.Q-PCR检测结果表明,AngⅡ能够明显刺激MDA-MB-231细胞中u PA(2.97倍)和u PAR的表达.因此,AngⅡ刺激乳腺癌细胞u PA和u PAR的表达,可能是AngⅡ促进乳腺癌细胞迁移的原因之一. Breast cancer is a high incidence and malignant tumor in women.The invasion and metastasis are the major reasons that leading to the death of patients.It is of great significance to study the factors and biomarkers associated with cancer metastasis.In this study,the migration of breast cancer cells MDA-MB-231 treated with the angiotensinⅡ(AngⅡ)was enhanced.The AngⅡsignificantly stimulated the expression of uPA(2.97 times)and uPAR in MDA-MB-231 cells by the Q-PCR measurement.Therefore,the AngⅡcould stimulate the expression of uPA and uPAR in breast cancer cells,which maybe one of the reasons promoting breast cancer cell migration by AngⅡ.
作者 曹令森 沈玮 曹祥荣 Cao Lingsen;Shen Wei;Cao Xiangrong(School of Life Sciences,Nanjing Normal University,Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology,Nanjing 210023,China)
出处 《南京师大学报(自然科学版)》 CAS CSCD 北大核心 2018年第1期83-87,共5页 Journal of Nanjing Normal University(Natural Science Edition)
基金 企业委托项目(K11100BY62).
关键词 血管紧张素Ⅱ UPA 乳腺癌细胞 AngⅡ uPA breast cancer cell
  • 相关文献

参考文献1

二级参考文献25

  • 1洪龙年,张颖.浅谈尿激酶型纤溶酶原激活系统与卵巢恶性肿瘤的相关性[J].当代医药论丛,2014,12(7):171-173. 被引量:1
  • 2郑杰.肿瘤的细胞和分子生物学[M].第2版.上海:上海科学技术出版社,2011:104-8.
  • 3Stepanova V, Lebedeva T, Kuo A, et al. Nuclear translocation of uro- kinase - type plasminogen activator [ J]. Blood, 2008, 112 ( 1 ) : 100 - 110.
  • 4Asuthkar S, Stepanova V, Lebedeva T, et al. Multifunctional roles of urokinase plasminogen activator (uPA) in cancer sternness and che- morcsistance of pancreatic cancer [ J ]. Mol Biol Cell, 2013, 24 ( 17 ) : 2620 - 2632.
  • 5Wu YJ, Neoh CA, Tsao CY, et al. Sinulariolide suppresses human hepatocellular carcinoma cell migration and invasion by inhibiting ma- trix metalloproteinase - 2/- 9 through MAPKs and P13K/Akt signa- ling Pathways[J]. Int J Mol Sci, 2015, 16(7): 16469-16482.
  • 6Lampelj M, Arko D, Cas -Sikosek N,et al. Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type - 1 (PAI - 1 ) in breast cancer - correlation with traditional prognostic factors [ J ]. Radiol Onco1,2015,49 (4) :357 - 364.
  • 7Noh H, Hong S, Huang S. Role of urokinase receptor in tumor pro- gression and development [ J ]. Theranostics, 2013,3 ( 7 ) :487 - 495.
  • 8Dutta S, Bandyopadhyay C, Bottero V, et al. Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration[ J]. Mol Oncol, 2014,8(3) :483 -507.
  • 9Smith HW, Marshall CJ. Regulation of cell signalling by uPAR[ J]. Nat Rev Mol Cell Biol, 2010,11 (1) :23 - 36.
  • 10Asuthkar S, Gondi CS, Nalla AK, et al. Urokinase - type plasmino- gen activator receptor (uPAR) - mediated regulation of WNT/β - catenin signaling is enhanced in irradiated medulloblastoma cells[ J]. J Biol Chem, 2012,287 ( 24 ) :20576 - 20589.

共引文献4

同被引文献12

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部